samedan logo
 
 
 
spacer
home > pmps > spring 2009 > peace of mind
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Peace of Mind

Protecting security of products in the pharmaceutical industry is becoming increasingly important on a worldwide scale. Regulatory requirements, patient protection and the growing incidence of product piracy call for decisive action. The specific objectives and security requirements of pharmaceutical corporations are as varied as the technological means available to address them. That is why successful product protection solutions have to be based on in-depth analyses and custom-tailored concepts.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Diethard Schaefer is a global key account manager at Schreiner MediPharm, one of the major divisions of Schreiner Group headquartered in Oberschleissheim near Munich. Diethard provides support to international pharmaceutical corporations, focusing on the development of intelligent, multi-functional product marking and security systems.
spacer
Diethard Schaefer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wasdell Group strengthens PPFL business with ISO 13485 for medical devices

The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has today announced that its Dundalk, Ireland facility has been certified to comply with the ISO 13485 standard for medical device manufacturing. The ISO 13485 is an internationally recognised certification, ensuring that the company’s quality management system complies to customer and applicable regulatory requirements.
More info >>

White Papers

Financial implications of off-site visits in clinical research, perception versus reality

Illingworth Research

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement